Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS
Authors:
- David VocadloDVDavid Vocadlo
- Charles KriegerCKCharles Krieger
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 458 (2) , 70-74
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseasesJournal of Neurology, 2009
- The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementiaCurrent Opinion in Neurology, 2008
- TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophyBMC Neuroscience, 2008
- Enrichment of C-Terminal Fragments in TAR DNA-Binding Protein-43 Cytoplasmic Inclusions in Brain but not in Spinal Cord of Frontotemporal Lobar Degeneration and Amyotrophic Lateral SclerosisThe American Journal of Pathology, 2008
- A90V TDP‐43 variant results in the aberrant localization of TDP‐43 in vitroFEBS Letters, 2008
- TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisThe Lancet Neurology, 2008
- Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALSNeuroscience Letters, 2007
- Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsAnnals of Neurology, 2007
- TDP‐43 in amyotrophic lateral sclerosis: Pathophysiology or patho‐babel?Annals of Neurology, 2007
- TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosisBiochemical and Biophysical Research Communications, 2006